Form 4: Annexon, Inc. Officer Jamie Dananberg Reports Sale of Common Stock

Chief Medical Officer Jamie Dananberg reports the sale of 5,521 shares of Annexon, Inc. common stock to cover tax obligations related to vesting restricted stock units.

Summary

• On February 18, 2025, Jamie Dananberg, Chief Medical Officer of Annexon, Inc., sold 5,521 shares of common stock.
• The sale was executed to cover tax withholding obligations related to the vesting of restricted stock units (RSUs).
• The shares were sold at a weighted average price of $2.96, with individual trades ranging from $2.855 to $3.12.
• Following the transaction, Dananberg directly owns 33,479 shares of Annexon, Inc. common stock.

Sentiment

Score: 5

Explanation: Neutral sentiment. This is a routine transaction to cover tax obligations, and doesn't necessarily reflect a positive or negative outlook on the company.

Industry Context

This is a routine Form 4 filing, indicating an insider transaction. It's common for executives to sell shares to cover tax obligations when restricted stock units vest. The impact on the stock price is likely to be minimal unless the transaction is unusually large or signals a change in the executive's outlook on the company.

Stakeholder Impact

• The sale of shares by an officer could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates

Keywords

Form 4, Insider Trading, Stock Sale, Jamie Dananberg, Annexon, Inc., ANNX, Chief Medical Officer, RSUs, Tax Withholding